Barclays »

Glucotrack shares owned by Barclays

Quarter-by-quarter ownership of Glucotrack (GCTK) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Glucotrack

Tip: Access up to 7 years of quarterly data

All positions including Glucotrack held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Glucotrack by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $401 1.3k 0.32
2025-06-30 $5.0k 751 6.66

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Glucotrack

Hrt Financial
Jane Street
Citadel Advisors
Ikarian Capital
Geode Capital Management
Virtu Financial
Granite Islands Private Wealth
Boothbay Fund Management
UBS Group
Susquehanna International
Alerus Financial
Tower Research Capital
Barclays
Tradewinds Capital Management
Newbridge Financial Services Group

View all funds holding Glucotrack